ArticleTurkish journal of ophthalmology2025

Evaluation of a New Potential Bevacizumab Biosimilar in Corneal Neovascularization.

Armağan Özgür et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.